Regeneron Pharmaceuticals (REGN)
(Real Time Quote from BATS)
$891.08 USD
-2.91 (-0.33%)
Updated Apr 19, 2024 11:58 AM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | 10.00 |
EPS Last Quarter | 11.86 |
Last EPS Surprise | 13.71% |
ABR | 1.56 |
Earnings ESP
|
0.13% |
---|---|
Current Year | 45.17 |
Next Year | 47.17 |
EPS (TTM) | 43.78 |
P/E (F1) | 19.79 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.17B | 3.39B | 14.04B | 15.13B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 3.29B | 3.56B | 14.73B | 15.78B |
Low Estimate | 3.06B | 3.15B | 13.21B | 13.92B |
Year ago Sales | 3.16B | 3.16B | 13.12B | 14.04B |
Year over Year Growth Est. | 0.40% | 7.41% | 7.03% | 7.76% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.00 | 11.03 | 45.17 | 47.17 |
# of Estimates | 11 | 9 | 12 | 11 |
Most Recent Consensus | 9.31 | 9.27 | 39.87 | 43.08 |
High Estimate | 11.62 | 12.60 | 52.60 | 56.40 |
Low Estimate | 9.05 | 9.27 | 39.87 | 41.73 |
Year ago EPS | 10.09 | 10.24 | 43.79 | 45.17 |
Year over Year Growth Est. | -0.89% | 7.71% | 3.15% | 4.41% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 1 | 2 | 1 |
Up Last 30 Days | 3 | 2 | 3 | 2 |
Up Last 60 Days | 3 | 2 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 10.00 | 11.03 | 45.17 | 47.17 |
7 Days Ago | 9.76 | 10.88 | 44.57 | 46.85 |
30 Days Ago | 9.76 | 10.86 | 44.54 | 46.78 |
60 Days Ago | 9.85 | 11.11 | 44.79 | 48.70 |
90 Days Ago | 10.68 | 11.26 | 44.28 | 49.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 10.02 | 11.02 | 43.96 | 48.26 |
Zacks Consensus Estimate | 10.00 | 11.03 | 45.17 | 47.17 |
Earnings ESP | 0.13% | -0.15% | -2.68% | 2.31% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 11.86 | 11.59 | 10.24 | 10.09 | NA |
Estimate | 10.43 | 10.80 | 9.92 | 9.25 | NA |
Difference | 1.43 | 0.79 | 0.32 | 0.84 | 0.85 |
Surprise | 13.71% | 7.31% | 3.23% | 9.08% | 8.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more